[Form 4] Cibus, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Kimberly A. Box, a director of Cibus, Inc. (CBUS), was granted a stock option on 09/11/2025 to purchase 54,722 shares of Class A common stock at an exercise price of $1.40 per share. The option vests on the earlier of the first anniversary of the grant date or the company’s next annual shareholders meeting, subject to continued service, and becomes exercisable beginning 09/11/2026 with an expiration date of 09/11/2035. The filing reports direct beneficial ownership of 54,722 shares following the grant. The grant includes standard acceleration on a defined Triggering Event per the company’s 2017 Omnibus Incentive Plan.

Insights

Financial Analyst

TL;DR: Routine director equity grant; modest dilution and standard multi-year exercise window suggest no immediate material market impact.

The 54,722-share option award at $1.40 is a typical form of non-cash compensation for a director and vests over approximately one year, with exercise starting in 2026 and expiring in 2035. Given the grant size relative to typical public-company share counts, this appears to be a routine governance practice rather than a strategic financing event. Investors should note the exercise price and potential dilution if exercised, but the filing itself contains no operational or financial performance information.

Corporate Governance Expert

TL;DR: Governance-standard award with service-based vesting and customary acceleration on defined Triggering Events.

The award follows the company’s 2017 Omnibus Incentive Plan terms, including vesting tied to continued board service and acceleration upon a Triggering Event. This aligns director incentives with shareholder value over a multi-year horizon. The filing discloses direct ownership and the key grant mechanics but does not provide board-level rationale or comparative peer benchmarking. As disclosed, the transaction is procedural and non-adverse from a governance standpoint.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Box Kimberly Ann

(Last) (First) (Middle)

6455 NANCY RIDGE DRIVE

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cibus, Inc. [ CBUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right-to-Buy)	$1.4	09/11/2025		A		54,722		09/11/2026(1)	09/11/2035	Class A Common Stock	54,722	$0	54,722	D

Explanation of Responses:

1. Subject to the Director's continued service, on the earlier of (a) the first anniversary of the Grant Date and (b) the date of the Company's next annual meeting of the shareholders following the Grant Date. Notwithstanding the foregoing, any unexpired, unvested Option will become vested as to the total number of shares underlying the Option if a Triggering Event (as defined in the Cibus, Inc. 2017 Omnibus Incentive Plan (the "Plan")) occurs and the Director provides continued service through the date of such Triggering Event.

	Jason Stokes, Attorney-in-Fact for Kimberly A. Box	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Kimberly A. Box report in the Form 4 for CBUS?

The filing reports a grant of a stock option to purchase 54,722 shares of Class A common stock at an exercise price of $1.40 per share.

When does the option become exercisable and when does it expire?

The option is exercisable beginning 09/11/2026 and expires on 09/11/2035.

What are the vesting conditions for the option granted to the director?

The option vests on the earlier of the first anniversary of the grant date or the company's next annual shareholders meeting, subject to the director's continued service, with acceleration upon a defined Triggering Event per the 2017 Omnibus Incentive Plan.

How many shares does the reporting person beneficially own after the transaction?

The reporting person beneficially owns 54,722 shares following the reported transaction.

What is the exercise price of the option reported on the Form 4?

The exercise price is $1.40 per share.